Cargando…

The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism

The introduction of adrenocortical extract in 1930 improved the life expectancy of hyhpoadrenal patients, with further increases seen after the introduction of cortisone acetate from 1948. Most patients are now treated with synthetic hydrocortisone, and incremental advances have been made with optim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choudhury, Sirazum, Tan, Tricia, Lazarus, Katharine, Meeran, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983484/ https://www.ncbi.nlm.nih.gov/pubmed/33449916 http://dx.doi.org/10.1530/EC-20-0473

Ejemplares similares

Inadvertent treatment of hypoadrenalism with prednisolone in pemphigus: A case report
por: Choudhury, Sirazum, et al.
Publicado: (2019)

Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement
por: Smith, David J F, et al.
Publicado: (2017)

Optimising prednisolone or prednisone replacement in adrenal insufficiency
por: Sharma, Angelica, et al.
Publicado: (2023)

Improving the Interpretation of Afternoon Cortisol Levels and SSTs to Prevent Misdiagnosis of Adrenal Insufficiency
por: Ramadoss, Vijay, et al.
Publicado: (2021)

Hydrocortisone/prednisolone: Various toxicities: case report
Publicado: (2021)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

Severe Hyponatremia With Partial Hypoadrenalism in Acute Porphyria
por: Marcus-Perlman, Yonit, et al.
Publicado: (2021)

Treatment of adrenal crisis in patients with primary hypoadrenalism can lead to hypertension
por: Nagamatsu, Fusa, et al.
Publicado: (2019)

Improved salivary cortisol rhythm with dual-release hydrocortisone
por: Ceccato, Filippo, et al.
Publicado: (2018)

Hydrocortisone associated hypomania in a child responding to shifting back to prednisolone
por: Grover, Sandeep, et al.
Publicado: (2014)

Hypoadrenalism as the Single Presentation of Autoimmune Polyglandular Syndrome Type 1
por: Nasser, Nadim H, et al.
Publicado: (2021)

Dual-release hydrocortisone treatment: glycometabolic profile and health-related quality of life
por: Mongioì, L M, et al.
Publicado: (2017)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

Avelumab inducing hypothyroidism and hypoadrenalism: A case report and review of literature
por: Aziz, Kashif, et al.
Publicado: (2018)

Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
por: Quinkler, Marcus, et al.
Publicado: (2016)

Comparison of Hydrocortisone Continuous Rate Infusion and Prednisolone or Dexamethasone Administration for Treatment of Acute Hypoadrenocortical (Addisonian) Crisis in Dogs
por: Mitropoulou, Athanasia, et al.
Publicado: (2022)

Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
por: Bioletto, Fabio, et al.
Publicado: (2023)

Modified-Release Hydrocortisone: Is It Time to Change Clinical Practice?
por: Stewart, Paul M
Publicado: (2019)

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021)

Unilateral adrenal infarction in pregnancy with associated acute hypoadrenalism and subsequent spontaneous biochemical and radiological resolution
por: Shah, Najeeb, et al.
Publicado: (2022)

Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
por: Gasco, V., et al.
Publicado: (2022)

Hydrocortisone/prednisolone: Prolonged viral shedding and cystic fibrosis-related diabetes following off-label use: 2 case reports
Publicado: (2022)

Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone
por: Espiard, Stéphanie, et al.
Publicado: (2020)

Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
por: Dineen, Rosemary A, et al.
Publicado: (2023)

Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection
por: Clarke, Sophie A, et al.
Publicado: (2021)

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

Exacerbation of hepatitis C induced subclinical hypoadrenalism by Interferon-alpha2beta: A case report
por: Tran, Huy A, et al.
Publicado: (2008)

SUN-358 Dual Release Hydrocortisone as a New Treatment for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Simeoli, Chiara, et al.
Publicado: (2019)

Spontaneous Adrenal Hemorrhage with Mild Hypoadrenalism in a Patient Anticoagulated with Apixaban for Antiphospholipid Syndrome: A Case Report and Literature Review
por: Tan, Jia Wei, et al.
Publicado: (2022)

Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study
por: Johannsson, Gudmundur, et al.
Publicado: (2016)

Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study
por: Guarnotta, Valentina, et al.
Publicado: (2019)

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010)

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency
por: Nilsson, A G, et al.
Publicado: (2014)

SAT-381 Cognitive Function and Quality of Sleep in Patients with Adrenal Insufficiency May Benefit by Therapy with Dual-Release Hydrocortisone
por: Krekeler, Clarissa, et al.
Publicado: (2019)

The impact of hydrocortisone treatment on neutrophil gelatinase-associated lipocalin release in porcine endotoxemic shock
por: Söderberg, E., et al.
Publicado: (2017)

Medical Uses of Cortisone, Including Hydrocortisone and Corticotropin
por: Bondy, Philip K.
Publicado: (1955)

The use of whole blood capillary samples to measure 15 analytes for a home-collect biochemistry service during the SARS-CoV-2 pandemic: A proposed model from North West London Pathology
por: Ansari, Saleem, et al.
Publicado: (2021)

Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients
por: Delle Cese, Francesca, et al.
Publicado: (2021)

PlenadrEMA: effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments: a study protocol for an open-label switch pilot study
por: Boesen, Victor Brun, et al.
Publicado: (2018)

Optimized Treatment for Infantile Spasms: Vigabatrin versus Prednisolone versus Combination Therapy
por: Hahn, Jongsung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fes5c0t66473719l7qpfbjk4av